Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
bristol-myers squibb
cancer
2
×
cancer immunotherapy
clinical trials
detroit blog main
2
×
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
nivolumab
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
2
×
seattle blog main
seattle top stories
texas blog main
texas top stories
2
×
wisconsin blog main
wisconsin top stories
abbvie
adalimumab (humira)
aducanumab
aduro biotech
affordable care act
alez azar
alzheimer's disease
antibiotics
What
companies
2
×
new
2
×
approval
bio
biogen’s
biopharmaceutical
biotechs
club
continued
convo
crop
drug
earlier
exceeded
failures
firms
group
haul
ipo
joined
latest
life
littered
met
million
momentum
nasdaq
nash
neon
news
offerings
positive
price
projections
public
raised
record
remains
road
rolls
Language
Current search:
new
×
cancer
×
" detroit blog main "
×
" texas top stories "
×
companies
×
" san francisco top stories "
×
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
6 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M